Gene Expression in MS Patients Before and During Treatment With Interferon-beta
Gene Expression in MS Patients Before and During Treatment With High-dose Interferon Beta: Prospective Study for the Identification of Predicting Factors of Therapeutic Response.
Sponsor: S. Andrea Hospital
Terminated
Few participants enrolled
Other terminated trials from S. Andrea Hospital
Other Multiple Sclerosis trials with similar outcome
A observational or N/A phase clinical study on Multiple Sclerosis, this trial is terminated or withdrawn. The trial is conducted by S. Andrea Hospital and has accumulated 7 data snapshots since 2004. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Jan 2021 — Jul 2024 [monthly]
Terminated
-
Jun 2018 — Jan 2021 [monthly]
Terminated
-
May 2018 — Jun 2018 [monthly]
Terminated
Status: Completed → Terminated
▶ Show 2 earlier versions
-
Apr 2018 — May 2018 [monthly]
Completed
Phase: PHASE4 → None
-
Jan 2017 — Apr 2018 [monthly]
Completed PHASE4
First recorded
Nov 2004
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- S. Andrea Hospital
For direct contact, visit the study record on ClinicalTrials.gov .